The Company will evaluate BNC210 in patients with SAD in the phase 2 PREVAIL trial.
Your search for major depressive disorder returned 4 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
The likelihood of help or harm, also known as the risk/benefit ratio, was found to be more favorable for lithium.
Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.
Latest News Your top articles for FridayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses